Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
NMTC
NEUROONE MEDICAL TECHNOLOGIES CORP
NASDAQ
Medical Devices
$33.78M$0.68-0.29%-$6.24M-3.08x2.96
United States
ABEO
ABEONA THERAPEUTICS INC
NASDAQ
Biotechnology
$290.57M$5.68-1.22%-$36.93M-6.93x1.40
United States
JBIO
JADE BIOSCIENCES INC
NASDAQ
Biotechnology
$8.27M$9.998.71%-$48.65M-0.17x0.03
United States
ORKA
ORUKA THERAPEUTICS INC
NASDAQ
Biotechnology
$419.71M$11.211.17%-$77.36M-6.19x0.03
United States
TNXP
TONIX PHARMACEUTICALS HOLDING CORP
NASDAQ
Biotechnology
$263.54M$35.983.12%-$129.22M-0.02x0.07
United States
NRXP
NRX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$56.36M$3.26-4.68%-$24.11M-1.62x-1.30
United States
ESTA
ESTABLISHMENT LABS HOLDINGS INC
NASDAQ
Medical Devices
$1.24B$42.714.35%-$57.63M-13.73x7.65
British Virgin Islands
ALDX
ALDEYRA THERAPEUTICS INC
NASDAQ
Biotechnology
$229.40M$3.831.06%-$55.54M-3.95x0.47
United States
JYNT
JOINT CORP
NASDAQ
Medical Care Facilities
$176.59M$11.541.05%-$4.68M-19.90x2.88
United States
ITRM
ITERUM THERAPEUTICS PLC
NASDAQ
Biotechnology
$39.80M$1.00-1.49%-$19.12M-1.05x-13.91
Ireland
CVAC
CUREVAC NV
NASDAQ
Biotechnology
$1.22B$5.430.93%$256.69M5.97x0.15
Germany
MXCT
MAXCYTE INC
NASDAQ
Medical Devices
$231.77M$2.18-0.91%-$36.95M-5.45x0.15
United States
NRSN
NEUROSENSE THERAPEUTICS LTD
NASDAQ
Biotechnology
$43.90M$1.89-0.53%-$10.19M-3.50x0.77
Israel
LUCY
INNOVATIVE EYEWEAR INC
NASDAQ
Medical Instruments & Supplies
$6.56M$2.121.92%-$7.42M-0.53x0.06
United States
TLSA
TIZIANA LIFE SCIENCES LTD
NASDAQ
Biotechnology
$176.11M$1.58-1.25%-$16.62M-14.36x1.87
United Kingdom
KURA
KURA ONCOLOGY INC
NASDAQ
Biotechnology
$499.54M$5.771.76%-$177.19M-2.75x1.04
United States
IKT
INHIBIKASE THERAPEUTICS INC
NASDAQ
Biotechnology
$144.97M$1.9520.37%-$36.52M-3.31x0.10
United States
BLCO
BAUSCH & LOMB CORP
NYSE
Medical Instruments & Supplies
$4.60B$13.014.92%$493.00M-12.63x1.10
Canada
PBM
PSYENCE BIOMEDICAL LTD
NASDAQ
Biotechnology
$3.03M$5.338.55%$1.03M1.02x0.09
Canada
NTHI
NEONC TECHNOLOGIES HOLDINGS INC
NASDAQ
Biotechnology
$67.93M$3.57-2.99%N/AN/A-1.88
United States
IBRX
IMMUNITYBIO INC
NASDAQ
Biotechnology
$2.33B$2.64-2.22%-$240.81M-4.89x-1.51
United States
VNDA
VANDA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$278.17M$4.72-1.26%-$47.73M-6.21x0.24
United States
TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE
Drug Manufacturers - Specialty & Generic
$48.66B$15.462.38%$7.92B65.51x1.05
Japan
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$352.84M$13.01-2.40%-$80.33M-5.14x0.42
United States
NNNN
ANBIO BIOTECHNOLOGY
NASDAQ
Biotechnology
$4.50B$31.661.44%$2.37M565.36x0.10
Germany
EVAX
EVAXION A
NASDAQ
Biotechnology
$3.44M$2.450.00%-$8.23M-0.25x-8.56
Denmark
NRXS
NEURAXIS INC
NYSEMKT
Biotechnology
$17.46M$2.42-2.42%-$8.19M-2.00x10.72
United States
RNAC
CARTESIAN THERAPEUTICS INC
NASDAQ
Biotechnology
$269.67M$10.39-2.72%-$33.79M-9.45x-19.78
United States
KLRS
KALARIS THERAPEUTICS INC
NASDAQ
Biotechnology
$49.94M$2.671.91%-$37.16M-0.32x0.61
United States
EVO
EVOTEC SE
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.49B$4.200.96%N/AN/A1.13
Germany
SGRY
SURGERY PARTNERS INC
NASDAQ
Medical Care Facilities
$2.85B$22.231.28%$348.10M-14.53x2.75
United States
NDRA
ENDRA LIFE SCIENCES INC
NASDAQ
Diagnostics & Research
$2.59M$3.51-1.96%-$9.57M-0.03x0.81
United States
SLN
SILENCE THERAPEUTICS PLC
NASDAQ
Biotechnology
$273.66M$5.800.17%-$68.00MN/A-0.64
United Kingdom
BDRX
BIODEXA PHARMACEUTICALS PLC
NASDAQ
Biotechnology
$0.00$0.87-0.57%-$7.32M-6.55x0.78
United Kingdom
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$27.41M$7.800.26%-$8.51M-1.51x0.93
United States
RMTI
ROCKWELL MEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$28.98M$0.857.07%$4.97M-42.40x0.71
United States
CLPT
CLEARPOINT NEURO INC
NASDAQ
Medical Devices
$334.19M$11.941.19%-$19.01M-15.71x0.50
United States
PACS
PACS GROUP INC
NYSE
Medical Care Facilities
$1.97B$12.92-0.54%N/AN/A5.80
United States
BNGO
BIONANO GENOMICS INC
NASDAQ
Medical Instruments & Supplies
$11.03M$3.28-0.30%-$70.02M-0.06x0.63
United States
BBIO
BRIDGEBIO PHARMA INC
NASDAQ
Biotechnology
$8.20B$43.18-3.74%-$539.06M-12.16x-1.53
United States
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$8.43B$17.04-2.07%-$3.56M-1,893.33x0.03
Hong Kong
ATYR
ATYR PHARMA INC
NASDAQ
Biotechnology
$451.25M$5.070.80%-$62.26M-6.34x0.30
United States
XNCR
XENCOR INC
NASDAQ
Biotechnology
$559.40M$7.86-3.44%-$158.22M-2.58x0.41
United States
MBOT
MICROBOT MEDICAL INC
NASDAQ
Medical Instruments & Supplies
$91.67M$2.520.80%-$11.60M-3.88x0.07
United States
PTGX
PROTAGONIST THERAPEUTICS INC
NASDAQ
Biotechnology
$3.43B$55.27-0.75%$59.97M61.41x0.08
United States
SDGR
SCHRODINGER INC
NASDAQ
Health Information Services
$1.48B$20.12-2.38%-$175.90M-7.65x0.99
United States
PRCT
PROCEPT BIOROBOTICS CORP
NASDAQ
Medical Devices
$3.19B$57.601.21%-$81.07M-34.08x0.34
United States
ENSC
ENSYSCE BIOSCIENCES INC
NASDAQ
Biotechnology
$5.29M$2.23-0.45%-$6.77M-0.34x0.62
United States
HROW
HARROW INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.12B$30.54-1.10%$18.65M-50.07x5.46
United States
ACTU
ACTUATE THERAPEUTICS INC
NASDAQ
Biotechnology
$119.88M$6.112.52%-$25.29M-1.59x-1.88
United States
AIRS
AIRSCULPT TECHNOLOGIES INC
NASDAQ
Medical Care Facilities
$283.91M$4.83-1.43%-$2.09M-16.66x1.63
United States
INMB
INMUNE BIO INC
NASDAQ
Biotechnology
$53.62M$2.31-56.66%-$40.80M-1.20x0.27
United States
ALZN
ALZAMEND NEURO INC
NASDAQ
Biotechnology
$2.13M$2.910.34%-$4.16M-0.11x0.21
United States
CAMP
CAMP4 THERAPEUTICS CORP
NASDAQ
Biotechnology
$29.23M$1.45-4.61%N/AN/A0.22
United States
FGEN
FIBROGEN INC
NASDAQ
Biotechnology
$21.42M$5.301.53%-$2.60M-2.12x-1.57
United States
EPIX
ESSA PHARMA INC
NASDAQ
Biotechnology
$75.46M$1.70-1.73%-$28.40M-2.70x0.02
Canada
LXRX
LEXICON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$343.57M$0.9515.23%-$164.27M-1.85x1.42
United States
HCWB
HCW BIOLOGICS INC
NASDAQ
Biotechnology
$5.71M$3.97-11.89%-$22.51M-0.16x-4.07
United States
NVNO
ENVVENO MEDICAL CORP
NASDAQ
Medical Devices
$69.97M$3.99-1.97%-$20.82M-3.38x0.06
United States
IBO
IMPACT BIOMEDICAL INC
NYSEMKT
Biotechnology
$7.82M$0.65-13.96%-$22.76M-0.27x3.45
United States
IMMX
IMMIX BIOPHARMA INC
NASDAQ
Biotechnology
$57.71M$2.07-4.61%-$20.70M-2.96x1.07
United States
ALGS
ALIGOS THERAPEUTICS INC
NASDAQ
Biotechnology
$44.09M$7.210.00%-$68.53M-0.70x0.29
United States
CCCC
C4 THERAPEUTICS INC
NASDAQ
Biotechnology
$101.54M$1.432.14%-$94.83M-0.97x0.64
United States
MREO
MEREO BIOPHARMA GROUP PLC
NASDAQ
Biotechnology
$430.89M$2.711.88%-$46.22M-7.74x0.14
United Kingdom
LQDA
LIQUIDIA CORP
NASDAQ
Biotechnology
$1.07B$12.46-4.89%-$110.63M-7.89x3.58
United States
ALUR
ALLURION TECHNOLOGIES INC
NYSE
Medical Devices
$18.12M$2.430.00%-$21.67M-0.20x-1.55
United States
VCEL
VERICEL CORP
NASDAQ
Biotechnology
$2.14B$42.551.97%$16.81M851.00x0.44
United States
INSM
INSMED INC
NASDAQ
Biotechnology
$18.33B$100.641.16%-$914.73M-16.97x17.18
United States
CTKB
CYTEK BIOSCIENCES INC
NASDAQ
Medical Devices
$430.64M$3.40-4.23%$8.03M0.00x0.27
United States
LENZ
LENZ THERAPEUTICS INC
NASDAQ
Biotechnology
$824.96M$29.31-2.88%-$47.65M66.61x0.05
United States
UPB
UPSTREAM BIO INC
NASDAQ
Biotechnology
$590.65M$10.980.46%N/AN/A0.02
United States
BIVI
BIOVIE INC
NASDAQ
Biotechnology
$17.17M$0.93-8.42%-$17.90M-0.57x0.13
United States
TRVI
TREVI THERAPEUTICS INC
NASDAQ
Biotechnology
$556.54M$5.47-2.67%-$47.23M-12.16x0.08
United States
TNON
TENON MEDICAL INC
NASDAQ
Medical Devices
$7.42M$0.982.84%-$13.11M-0.18x0.43
United States
ANAB
ANAPTYSBIO INC
NASDAQ
Biotechnology
$652.25M$22.20-1.20%-$138.18M-4.63x11.41
United States
OM
OUTSET MEDICAL INC
NASDAQ
Medical Devices
$340.45M$19.210.73%-$84.88M-0.66x0.77
United States
NIVF
NEWGENIVF GROUP LTD
NASDAQ
Medical Care Facilities
$11.84k$1.040.97%-$26.43k-0.08x-4.83
Thailand
ELAB
PMGC HOLDINGS INC
NASDAQ
Biotechnology
$2.97M$2.160.93%-$5.74M0.08x0.09
United States
PROK
PROKIDNEY CORP
NASDAQ
Biotechnology
$173.28M$0.59-11.51%-$62.60M-0.99x-0.04
United States
ENTA
ENANTA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$161.61M$7.560.80%-$87.12M-1.67x2.45
United States
HUMA
HUMACYTE INC
NASDAQ
Biotechnology
$324.20M$2.09-1.42%-$59.92M-3.03x3.51
United States
RYTM
RHYTHM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$4.02B$63.190.73%-$146.33M-22.49x11.80
United States
INO
INOVIO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$74.63M$2.04-3.55%-$93.37M-0.64x0.70
United States
MDWD
MEDIWOUND LTD
NASDAQ
Biotechnology
$209.16M$19.370.57%-$18.84M-9.50x1.21
Israel
SERA
SERA PROGNOSTICS INC
NASDAQ
Diagnostics & Research
$104.35M$2.77-32.27%-$31.55M-2.95x0.25
United States
STSS
SHARPS TECHNOLOGY INC
NASDAQ
Medical Instruments & Supplies
$5.55M$5.450.00%-$3.41M-0.00x0.87
United States
IINN
INSPIRA TECHNOLOGIES OXY BHN LTD
NASDAQ
Medical Devices
$20.61M$0.850.00%-$10.84M-1.42x0.87
Israel
GLMD
GALMED PHARMACEUTICALS LTD
NASDAQ
Biotechnology
$3.04M$1.841.66%-$7.82M-0.26x0.11
Israel
KIDS
ORTHOPEDIATRICS CORP
NASDAQ
Medical Devices
$532.04M$21.480.51%-$19.85M-12.20x0.36
United States
CGON
CG ONCOLOGY INC
NASDAQ
Biotechnology
$1.98B$26.000.19%-$105.54M-17.22x0.03
United States
ALLR
ALLARITY THERAPEUTICS INC
NASDAQ
Biotechnology
$15.23M$1.011.00%-$23.16M-0.64x0.59
United States
QTTB
Q32 BIO INC
NASDAQ
Biotechnology
$18.17M$1.492.76%-$58.70M-0.30x-20.70
United States
DBVT
DBV TECHNOLOGIES SA
NASDAQ
Biotechnology
$250.89M$9.163.15%-$113.67M-1.61x16.60
France
OKUR
ONKURE THERAPEUTICS INC
NASDAQ
Biotechnology
$32.29M$2.39-0.42%-$59.08M-0.17x0.10
United States
ICCM
ICECURE MEDICAL LTD
NASDAQ
Medical Devices
$58.38M$1.00-1.39%-$15.37M-3.56x0.85
Israel
SPRY
ARS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.71B$17.45-4.12%-$15.01M-102.65x0.43
United States
NOTV
INOTIV INC
NASDAQ
Diagnostics & Research
$62.52M$1.827.06%$5.65M-0.57x3.86
United States
RCEL
AVITA MEDICAL INC
NASDAQ
Medical Devices
$139.84M$5.29-2.94%-$49.49M-2.42x-16.20
United States
SMMT
SUMMIT THERAPEUTICS INC
NASDAQ
Biotechnology
$15.80B$21.283.30%-$231.98M-7,093.33x0.12
United Kingdom
GALT
GALECTIN THERAPEUTICS INC
NASDAQ
Biotechnology
$133.55M$2.11-9.44%-$38.92M-2.93x-1.07
United States
1...456...12

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
651-0.07%+1.10%+4.37%-72.44%-123.86x4.44x-78.67%-3.10%+5.17%+105.56%Strong Buy
57+0.02%+1.65%+4.66%-17.54%19.52x3.55x-11.03%+5.90%+10.56%+14.93%Buy
18+0.54%+1.50%+1.58%-13.08%37.73x5.91x+50.79%+9.87%+16.81%+55.13%Buy
77-0.20%-1.18%-0.92%-59.75%-31.27x2.23x+9.58%+4.64%+10.61%+41.40%Buy
11+1.16%+3.70%+2.47%-19.89%14.43x2.06x+16.73%+5.27%+12.28%+22.13%Buy
56+1.51%+5.34%+1.80%-62.52%46.11x4.04x+8.05%+4.31%+9.42%+17.41%Buy
48-2.43%-0.68%-2.57%-8.93%16.78x4.66x-73.33%+6.80%+14.32%+20.95%Buy
139+0.29%+2.58%+1.96%-8.32%37.15x4.13x+8.21%+8.33%+8.98%+29.22%Strong Buy
10+0.68%+1.98%+3.36%+28.63%29.20x1,406.44x-0.53%+3.60%+22.82%+3.20%Buy
56+0.50%+2.56%+0.99%-59.98%41.77x3.70x+10.31%+8.51%+10.99%+25.14%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: A.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 48, which is 23 points higher than the healthcare sector average of 25. It passed 17 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 49.88% over the past year, overperforming other healthcare stocks by 102 percentage points.

Phibro Animal Health has an average 1 year price target of $24.00, a downside of -6.03% from Phibro Animal Health's current stock price of $25.54.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

2. Enhabit (NYSE:EHAB)


Enhabit (NYSE:EHAB) is the #2 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Enhabit (NYSE:EHAB) is: Value: C, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: B, and AI: C.

Enhabit (NYSE:EHAB) has a Due Diligence Score of 7, which is -18 points lower than the healthcare sector average of 25. Although this number is below the industry average, our proven quant model rates EHAB as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Enhabit has seen its stock return 10.17% over the past year, overperforming other healthcare stocks by 62 percentage points.

3. Trubridge (NASDAQ:TBRG)


Trubridge (NASDAQ:TBRG) is the #3 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: C, Growth: A, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: C.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 14, which is -11 points lower than the healthcare sector average of 25. Although this number is below the industry average, our proven quant model rates TBRG as a "A".It passed 5 out of 38 due diligence checks and has weak fundamentals. Trubridge has seen its stock return 121.57% over the past year, overperforming other healthcare stocks by 173 percentage points.

Trubridge has an average 1 year price target of $28.50, an upside of 21.69% from Trubridge's current stock price of $23.42.

Trubridge stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Trubridge, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)


Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 12.53%, which is 11 percentage points higher than the healthcare sector average of 1.97%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)


Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 7.71%, which is 6 percentage points higher than the healthcare sector average of 1.97%.

Cryo Cell International's dividend payout ratio of 5,000% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.07%, which is 5 percentage points higher than the healthcare sector average of 1.97%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 160.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.06% in the last day, and up 1.69% over the last week. Artelo Biosciences was the among the top gainers in the healthcare sector, gaining 95.43% yesterday.

Artelo Biosciences shares are trading higher after the company announced data from its first-in-human study for ART26.12.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 26 points higher than the healthcare sector average of 17. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 4.57% in the past year. It has overperformed other stocks in the healthcare sector by 56 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.88% in the past year. It has overperformed other stocks in the healthcare sector by 56 percentage points.

3. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Inmode's stock has dropped -19.19% in the past year. It has overperformed other stocks in the healthcare sector by 33 percentage points.

Are healthcare stocks a good buy now?

50.9% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 47.93% over the next year.

4.68% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.52% of healthcare stocks are rated B (Buy), 44.66% are rated C (Hold), 25.69% are rated D (Sell), and 13.45% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 6.71x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.